scoparianoside b has been researched along with anacardic acid in 1 studies
| Studies (scoparianoside b) | Trials (scoparianoside b) | Recent Studies (post-2010) (scoparianoside b) | Studies (anacardic acid) | Trials (anacardic acid) | Recent Studies (post-2010) (anacardic acid) |
|---|---|---|---|---|---|
| 5 | 0 | 4 | 177 | 1 | 120 |
| Protein | Taxonomy | scoparianoside b (IC50) | anacardic acid (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.8 | |
| Histone acetyltransferase p300 | Homo sapiens (human) | 7.4125 | |
| Histone acetyltransferase KAT2B | Homo sapiens (human) | 5 | |
| SUMO-activating enzyme subunit 1 | Homo sapiens (human) | 2.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, D; Wu, X | 1 |
1 review(s) available for scoparianoside b and anacardic acid
| Article | Year |
|---|---|
Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
Topics: Humans; Neoplasms; Protein Processing, Post-Translational; Small Ubiquitin-Related Modifier Proteins; Sumoylation; Ubiquitin | 2022 |